Convergene

Developing dual inhibitors for rare diseases and cancer therapies

placeGaithersburg, Maryland, United States calendar_todayFounded 2011 groups5 employees language convergenepharma.com

1 investor on record.

Investor type	Count	Share
Venture capital	1	100%

Coming soon